Connect with us

Technology

$101M XPRIZE HEALTHSPAN AWARDS FIRST MILESTONE WINNERS DRIVING TOWARD REVOLUTIONARY HEALTHY AGING ADVANCES

Published

1 year ago

on

Over 600 competing teams from 58 countries entered global competition. Teams with a broad range of potential solutions for healthspan extension awarded in first round.

NEW YORK, May 12, 2025 /PRNewswire/ — XPRIZE, the world’s leader in designing and operating large-scale incentive competitions to solve humanity’s grand challenges, today announced the first Milestone award winners and top semifinalist teams competing in the next stage of its XPRIZE Healthspan, a $101 million, 7-year global competition incentivizing teams to develop and test therapeutics to improve healthy aging and close the gap between life and health expectancy. XPRIZE also announced the eight finalist teams competing for the $10M Facioscapulohumeral muscular dystrophy (FSHD) Bonus Prize. The announcement was made today at the XPRIZE Healthspan Awards Ceremony in New York City.

Global life expectancy has more than doubled in the last 100 years, but the quality of our health as we age has not increased at the same rate. In the U.S. there is currently a 12-year gap between life expectancy and healthy life expectancy, or the period of life free of major chronic disease or disability. Launched in November 2023, the $101M XPRIZE Healthspan is the first health-focused competition of its kind, incentivizing teams to develop proactive, accessible therapeutic solutions that restore muscle, cognition, and immune function by a minimum of 10 years, with a goal of 20 years, in persons aged 50-80 years, in one year or less.

“The next breakthrough in aging could come from scientists and entrepreneurs, anywhere. With this prize, we’re igniting a global healthspan revolution, and these semifinalists are leading the charge,” said Peter H. Diamandis, MD, founder and executive chairman of XPRIZE. “This competition isn’t just accelerating progress, it’s challenging our society’s beliefs in what’s possible when it comes to aging.”

From over 600 registered teams across 58 countries, the Top 100 teams are recognized as semifinalists, with the Top 40 Healthspan teams and Top 8 FSHD Bonus Prize teams selected as Milestone 1 award winners based on their proposed therapeutic solution, scientific rationale, supporting evidence, strengths of team and clinical center, and proposals for clinical testing. Each Milestone 1 winner was awarded $250,000 to support their ongoing work and conduct clinical trials in the next phase of the competition.

The most prevalent solutions submitted by XPRIZE Healthspan teams fall into broad categories such as: biologic therapies, drugs and small molecules, lifestyle interventions, medical devices, and nutraceuticals and functional foods. Many teams indicate intent to pursue integrated, personalized strategies, combining approaches, like dietary interventions paired with new or generic drugs or even cell therapies. The teams propose therapies that affect a wide range of biological systems, from metabolism and inflammation to stem cells, and may have general health effects or specific targets like the mitochondria or the growth of neurons. No single system or approach dominates, highlighting the diversity of solutions being explored through the competition.

“We are thrilled by the unprecedented global response to this competition, and the powerful, innovative thinking and approaches we’re seeing proposed by these teams,” said Jamie Justice, Ph.D., executive director, XPRIZE Healthspan. “Our semifinalist teams are exploring a diverse array of strategies to extend healthspan, from biologics and devices to drugs, lifestyle interventions, and personalized monitoring, coupling breakthrough innovations with feasibility and safety. We’re encouraged by these initial results and are eager to see how these solutions progress as they move toward clinical trials.”

Note, registration in this competition remains open and teams are continuing to register to participate in follow-on rounds and the grand prize.

The following teams have been selected to advance as XPRIZE Healthspan Top 40 Milestone 1 awardees:

A NEW DIMENSION, San Jose, CA ABE YOANDO PHARMA CO LTD,
Adachi, Tokyo, Japan AGELESSRX, Ann Arbor, MI ANI BIOME, San Francisco, CA AUTOPHAGYGO, Osaka, Japan BIOAGE LABS, California, USA BIOARMOR, Kuala Lumpur, Malaysia BOSTON HEALTHSPAN TEAM,
Boston, MA CANADIAN TRANSLATIONAL
GEROSCIENCE NETWORK,
Montreal, Quebec, Canada CIRCADIAN, San Diego, CA EXOMED, New South Wales,
Australia GI INNOVATION, Seoul, South Korea GODA LAB, Bunkyo City, Tokyo,
Japan HEALTHY LONGEVITY CLINIC,
Boca Raton, FL INTERVENE IMMUNE, Los Angeles,
CA, PROMETHEUS CELL TEAM,
Shanghai, China REJUVENATION THROUGH LOW FREQUENCY ULTRASOUND, San
Antonio, TX RPRGAON-PROGERIA, Busan,
South Korea SANJEEVINI, Mumbai, India TEAM GLYNAC, Houston, TX THE HEALTHY BODY AND MIND,
St. Louis, MO TIME TRAVELER AND CURREIO,
Tokyo, Japan TIMELINE, Lausanne, Switzerland UNIVERSITY HOSPITAL INSTITUTE (IHU) HEALTHAGE, Occitanie, Haute
Garonne VITA, Barcelona, Spain YOXLO, Oegstgeest, Netherlands

 

JAPAN LONGEVITY CONSORTIUM,
Tokyo, Japan KIMERA LABS, Miami, FL LIONHEART HEALTH INC, Newport
Beach, CA LOGIN (LONGEVITY INNOVATOR),
Sendai Miyagi, Japan LONGEVERON INC, Miami, FL LONGEVITY IMMUNOTHERAPY,
Irvine, CA LONO JAEYAK, Gunsan Jeonbuk-
do, South Korea METFORMIN FOR HEALTHSPAN EXTENSION (METHEALTHSPAN),
New York, NY MINICIRCLE, Austin, TX MITO-TAGS, Palo Alto, CA MITOCHONDRIAL ALL-STARS,
Needham, MA MITOCHONDRIAL BIOENERGETICS AND KETONE UTILIZATION, San Diego, CA NUS ACADEMY FOR HEALTHY
LONGEVITY, Singapore NYC-VITA, New York, NY

 

All semifinalist teams – Top 100 and late-registering teams included – will begin early stage clinical trials over the next year and will submit their data in April 2026 for the next round of judging in the Healthspan competition. Translating findings from the lab to clinical testing is a major hurdle for teams as it requires safety assessment, regulatory approval, testing partners, and investors or funders. In July 2026, XPRIZE will announce the 10 finalists selected to receive the second $10 million milestone prize. These teams will then advance to finals and must test their therapeutic solution for up to one year in adults aged 50-80 years in clinical trials, running from 2026 to 2029. The finalists’ trials will be supported by the University of Utah and its Data Coordinating Center (DCC), which will serve as the DCC for XPRIZE Healthspan. The competition will culminate in 2030, when the grand prize winner is awarded up to $81 million.

“Hevolution Foundation is dedicated to revolutionizing the healthspan science field and transforming the way we approach aging, as demonstrated by our support as the single-largest funder of XPRIZE Healthspan,” said Dr. Mehmood Khan, CEO of Hevolution Foundation and Co-Title Sponsor of XPRIZE Healthspan. “We are thrilled with the progress made at this pivotal prize milestone and are eager to see how these promising solutions evolve. Together, we are driving toward the goal to propel aging research forward globally and achieve medical breakthroughs to help humanity live healthier, longer.”

FSHD Bonus Prize

The FSHD Bonus Prize is designed to ignite solutions for FSHD, a genetic disease that impacts muscular function that has limited treatment options due to its complexity. Eight finalist teams received $250,000 each for demonstrating feasible FSHD solutions, an equal split of the $2 million Milestone 1 prize purse. The FSHD Bonus Prize will be awarded to the team that best demonstrates the ability to restore lost muscular function due to FSHD in one year or less and the first place team will receive $8 million.

The finalist teams include:

Altay Therapeutics Inc., San Carlos, CAAni Biome, San Francisco, CAArmatus Bio, Columbus, OHAsagi Labs, Nagano, JapanBeat-FSHD, Los Angeles, CAEpicrispr Biotechnologies, Inc., San Francisco, CAModalis Therapeutics Corporation, Tokyo, JapanSNPM/Chu De Nice, Nice, France

“Chronic diseases like muscular dystrophy are a major contributor to the gap between lifespan and healthspan. New solutions are essential for people to live healthier, longer lives,” said Chip Wilson, Founder and Chairman of SOLVE FSHD and Co-Title Sponsor of XPRIZE Healthspan. “XPRIZE Healthspan and SOLVE FSHD are here to push the boundaries of what healthy aging can look like. The next five years are going to show us what’s possible.”

XPRIZE Healthspan is offered with support from Co-Title Sponsors Hevolution Foundation and Chip Wilson, founder and chairman of SOLVE FSHD. GSK, a global biopharma company joins XPRIZE Healthspan as the Official Pharmaceutical Industry partner. Additional contributions from individual benefactors include Christian Angermayer, Carl B. Barney, the Blundy Family, Kas Bordier, Peter H. Diamandis, Charlie and Lorie Epstein, the Eleanor and Howard Morgan Family Foundation, Dana and Rob Hamwee, Daniel Krizek, Nancy and Howard Marks, Chris Ouwinga, Christian Peneff, SeneGence, Mark S. Siegel, Todd and Karen Wanek, Sergey Young, and an anonymous donor. Global scientific advisors, including the Scientific Director at National Institute on Aging, Senior Scientific Director at American Federation for Aging Research, Director of the UCLA Broad Stem Cell Research Center, and Head of Clinical Medicine at University of Cambridge, have helped inform the prize design and will advise in various capacities throughout the competition.

Learn more and get involved at xprize.org/healthspan.

About XPRIZE
XPRIZE is the recognized global leader in designing and executing large-scale competitions to solve humanity’s greatest challenges. For over 30 years, our unique model has democratized crowd-sourced innovation and scientifically scalable solutions that accelerate a more equitable and abundant future. Donate, learn more, and co-architect a world of abundance with us at xprize.org.

About Hevolution
Founded on the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is a global catalyst, partner, and convener on a mission to drive efforts to extend healthy human lifespan and understand the processes of aging. With a focus on aging as a treatable process, Hevolution Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development, and increase accessibility to therapeutics that extend healthy lifespan, also known as healthspan. A global non-profit organization headquartered in Riyadh with a North American hub and an annual budget of up to $1 billion, Hevolution Foundation plans to open offices in other global locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer. Learn more at hevolution.com

About SOLVE FSHD
SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD, established by renowned Canadian entrepreneur and philanthropist, Chip Wilson. The Wilson family has committed $100 million to kick-start funding into projects that support the organization’s mission to find a cure for FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD. If you want to find out more about our efforts at SOLVE FSHD, please see our website – solvefshd.com

About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.

Media Contact:
Katy Frame 
kframe@brgcommunications.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/101m-xprize-healthspan-awards-first-milestone-winners-driving-toward-revolutionary-healthy-aging-advances-302452290.html

SOURCE XPRIZE Foundation

Related Topics:
Continue Reading

Technology

Mission Critical Partners Announces Launch of its Justice Integration Hub in Support of the City of New Orleans

Published

25 minutes ago

on

October 27, 2026

By

The $30 million ARPA-funded initiative connects public-safety and justice agencies, accelerates case processing and improves service to the community.

NEW ORLEANS, Oct. 27, 2026 /PRNewswire-PRWeb/ — Mission Critical Partners today announced the launch of its Justice Integration Hub in support of the city of New Orleans’ Justice Technology Modernization Program (JTMP). JTMP is a multiyear initiative that replaced several decades-old systems with a unified, cloud-based platform designed to improve public safety and access to justice by streamlining operations and strengthening transparency across the city and Orleans Parish criminal-justice ecosystem.

“The Justice Integration Hub is not just a technology milestone; it’s a fundamental shift in how justice is delivered,” said Darrin Reilly, president and CEO, Mission Critical Partners.

The Justice Integration Hub facilitates the seamless flow of information throughout the Parish’s complex criminal-justice ecosystem. Funded through a $30 million allocation from the American Rescue Plan Act (ARPA), JTMP represents one of the most comprehensive justice technology overhauls in the country, modernizing and transforming more than 40 years of legacy infrastructure. The program integrates the area’s entire criminal justice ecosystem — including the New Orleans Police Department, Orleans Parish Sheriff’s Office and Justice Center, District Attorney, Public Defender, Criminal District Court, and Clerk of Court — into a single, connected environment.

“The integration hub fundamentally changes how our justice agencies work together,” said Nathaniel Weaver, JTMP director. “Instead of information stopping at the boundaries between agencies, it can move securely in real time, allowing people to spend less time reentering data and more time making the decisions that move cases forward.”

From Fragmentation to Real-Time Coordination

For years, criminal-justice agencies in New Orleans and Orleans Parish operated on outdated, siloed systems that limited collaboration, slowed case processing, and created cross-department inefficiencies.

The Justice Enterprise Hub is built on Microsoft Azure and leverages a standardized enterprise data model aligned with national data-sharing models. A secure integration hub enables real-time data sharing across agencies, ensuring that critical information is accessible when and where it is needed.

Immediate Impact Across the Community

The Justice Enterprise Hub already is helping to deliver measurable improvements:

Patrol officers now have additional hours each week to spend in New Orleans communities and respond to emergencies due to more efficient digital arrest-processing workflows.Data sharing from the jail to the court facilitates automated creation of cases and scheduling of court appearances, saving approximately 6,000 hours of time clerks would spend on data entry.Faster information sharing between agencies is helping reduce hearing delays, streamline inmate transport coordination, and improve overall justice system efficiency. This significantly reduces incarceration costs and generates measurable operational savings.

A Foundation for the Future of Justice

With the core platform now fully operational, New Orleans and Orleans Parish are positioned to build on this foundation with advanced capabilities, including AI-assisted case processing, digital evidence management, and expanded state-level data integration.

“The Justice Integration Hub is not just a technology milestone; it’s a fundamental shift in how justice is delivered,” said Darrin Reilly, MCP’s president and CEO. “New Orleans and Orleans Parish now have a nation-leading, scalable, and future-ready system that enables agencies to work together more effectively and collaboratively to better serve the public. We look forward to bringing this solution to more communities across the nation.”

The system was implemented in four phases, following a competitive nationwide process that selected Mission Critical Partners and Major Services, a New Orleans-based IT consulting firm, to oversee JTMP’s development, implementation, and coordinated go-live activities across all participating agencies. Those four phases went live in succession, between November 2025 and April 2026.

About Mission Critical Partners (MCP)

Mission Critical Partners (MCP) is a leading provider of data integration, consulting, network, and cybersecurity solutions specializing in transforming mission-critical communications networks into integrated ecosystems that improve outcomes in the public-safety, justice, healthcare, transportation, and utility markets. Our comprehensive experience and vendor-agnostic approach help us develop modernized solutions that maximize value, improve efficiency, and mitigate risk. Additional information and career opportunities are available at MissionCriticalPartners.com.

Media Contact

Morgan Sava, Mission Critical Partners, 1 608-658-8858, rscarpino@pipitone.com, https://www.missioncriticalpartners.com/

View original content:https://www.prweb.com/releases/mission-critical-partners-announces-launch-of-its-justice-integration-hub-in-support-of-the-city-of-new-orleans-302920918.html

SOURCE Mission Critical Partners

Continue Reading

Technology

MadeAi Launches Dossier Expert, Bringing Agentic AI to Formulary and Value Dossier Development

Published

25 minutes ago

on

October 27, 2026

By

New AI-powered solution transforms dossier creation and maintenance with source-level traceability, cross-functional collaboration, and up to 70% faster authoring and updates

CAMBRIDGE, Mass., Oct. 27, 2026 /PRNewswire-PRWeb/ — MadeAi™, a leader in AI-enabled evidence synthesis and life sciences solutions, today announced the launch of MadeAi Dossier Expert, a new AI-powered solution designed to transform how pharmaceutical and life sciences organizations create, review, and maintain formulary and value dossiers.

Traditionally, developing AMCP dossiers, global value dossiers, and health technology assessment (HTA) submissions requires months of coordination across HEOR, Clinical, Market Access, and Medical Writing teams. Evidence is dispersed across multiple sources, citations require extensive manual verification, and updates often trigger lengthy rounds of rewriting and review.

Dossier Expert replaces this fragmented process with a living, evidence-linked document that evolves as the underlying science changes.

Built to address one of the most time-consuming challenges facing Market Access and HEOR teams, Dossier Expert brings evidence management, AI-assisted authoring, citation verification, and cross-functional collaboration into a single, continuously updated environment.

From Static Documents to Living Evidence

Unlike traditional dossier authoring approaches that focus primarily on accelerating initial drafts, Dossier Expert is designed to streamline the entire dossier lifecycle—from first creation through ongoing evidence updates.

Key capabilities include:

AI-Powered Dossier Generation: Create structured AMCP, HTA, and value dossiers using customizable templates and AI-generated, evidence-grounded content.One-Click Citation Verification: Trace every AI-generated claim directly to its source document, with the supporting passage highlighted for immediate verification.Intelligent Evidence Updates: Automatically identify sections affected by changes in underlying evidence and selectively regenerate outdated content without overwriting human edits.Integrated Evidence Hub: Organize and connect indexed source materials directly to relevant dossier sections.Integrated MadeAi-LR: Access AI-enabled literature review directly for in-platform literature review support.Seamless Collaboration: Enable HEOR, Clinical, Market Access, and Medical Writing teams to work within one document, with built-in commenting, assignments, approvals, and version control.Flexible, Submission-Ready Outputs: Export approved dossiers to Word or PDF.

Accelerating Market Access Without Compromising Scientific Rigor

Dossier Expert is designed to deliver up to 70% faster dossier authoring and updates, while reducing the manual effort associated with evidence verification, document management, and recurring revisions.

“Creating a dossier is only part of the challenge. Keeping it scientifically current, fully traceable, and aligned across multiple stakeholders is where organizations lose enormous amounts of time,” said Gaugarin Oliver, Founder and CEO of MadeAi. “With Dossier Expert, we’re moving beyond AI-generated first drafts to a fundamentally different model: a living dossier that connects every claim to its evidence, identifies what needs updating, and enables experts to focus on scientific judgment rather than document administration.”

By combining AI-powered efficiency with human oversight and transparent source verification, Dossier Expert helps life sciences organizations accelerate evidence communication while maintaining the rigor required for payer and HTA engagement.

Learn more about Dossier Expert at www.madeai.com.

About MadeAi

MadeAi™ is an award-winning AI-native evidence synthesis and life sciences solutions platform designed to help pharmaceutical, biotechnology, and medical device organizations accelerate evidence generation and scientific communication. Combining advanced agentic AI capabilities with human expertise, MadeAi supports workflows across HEOR, Market Access, Medical Affairs, and RWE, delivering greater efficiency, transparency, and scientific rigor.

Media Contact

Meghan Oates-Zalesky, MadeAi, 1 617 435 2470, meghan.oates@madeai.com, www.madeai.com

View original content to download multimedia:https://www.prweb.com/releases/madeai-launches-dossier-expert-bringing-agentic-ai-to-formulary-and-value-dossier-development-302920940.html

SOURCE MadeAi

Continue Reading

Technology

Peloton Launches Peloton Broker to Streamline Early-Stage Land Acquisition for Energy Projects

Published

25 minutes ago

on

October 27, 2026

By

New tract-based pre-leasing tool joins the
Land Data Management solution in the Peloton Platform

CALGARY, AB, Oct. 27, 2026 /PRNewswire/ — Peloton, a provider of energy data management software, today announced the launch of Peloton Broker, a tract-based pre-leasing management tool built for energy projects. Peloton Broker gives brokers, consultants, land departments, and legal teams one place to handle ownership discovery, negotiation tracking, and title curative work, so they can move from prospect to signed lease without re-entering data or juggling separate systems.

Peloton Broker is part of Peloton’s Land Data Management solution in the Peloton Platform, alongside LandView, LandView Map, and Peloton Dashboards. It extends Peloton’s trusted foundation to the earliest stage of land acquisition, with pre-leasing work carrying straight into agreement-based lease management in LandView.

“The pre-leasing stage has always been where land data is most scattered, with ownership research in one place, negotiation notes in another, and title issues surfacing late,” said James Hatcher, Product Manager – Land Data Management at Peloton. “Peloton Broker brings that work into the Peloton Platform from day one, so land teams start every lease with a complete picture and the rest of the organization gets land data it can trust.”

Built for the start of the lease lifecycle

Peloton Broker helps land teams at oil and gas operators and renewable energy developers:

Track ownership at the tract level, covering both surface and mineral rightsManage negotiations in integrated workflows that record every offer, contact, and status changeCatch title concerns early with title curative support, before they hold up executionWork from the map with GIS-driven prospect management connected to LandView MapKeep audit-ready records with full traceability from first contact to executed lease

Connected across the Peloton Platform

The Peloton Platform is a SaaS solution hosted by Microsoft Azure that brings well, production, and land data together in one environment. With Peloton Broker on the platform, customers get:

A single source of truth. Land, operations, and finance teams work from the same accurate, up-to-date information, with master data such as business associates, wells, and units shared across products.Linked lifecycles. Land data ties into well and production data in WellView and ProdView, and integrates with third-party ERP and financial systems.Enterprise-grade security, backed by Peloton’s SOC 1 and SOC 2 Type 2 certifications.

Peloton Broker is available now. To learn more, visit peloton.com/products/land-data-management/broker.

About Peloton

Headquartered in Calgary, Alberta, and founded in 1991, Peloton created the energy industry’s original data management solution, and it remains the standard today. With more than three decades of industry expertise and over 700 clients globally, Peloton offers software across the well, production, and land lifecycles. The Peloton Platform brings all three together in one integrated SaaS environment, hosted by Microsoft Azure.

View original content to download multimedia:https://www.prnewswire.com/news-releases/peloton-launches-peloton-broker-to-streamline-early-stage-land-acquisition-for-energy-projects-302921122.html

SOURCE Peloton Computer Enterprises Ltd.

Continue Reading

Trending